Skip to Content
Nov. 5, 2013, 10:43 AM
UPDATE: Due to unforeseen circumstances, the Rollin A. Daniel Jr. M.D. Lecture scheduled for Nov. 22 has been canceled. It will be rescheduled for a later date.
Pioneering cardiothoracic surgeon James L. Cox will speak on the history and future of atrial fibrillation therapies at 7 a.m. Friday, Nov. 22, in 208 Light Hall. His talk is the 35th annual Rollin A. Daniel Jr. M.D. Lecture sponsored by the departments of Cardiac Surgery, Thoracic Surgery and Pediatric Cardiac Surgery.
Cox is the Evarts A. Graham Professor of Surgery, Emeritus, and chief of the Division of Cardiothoracic Surgery, emeritus, at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis. He is also the chairman and CEO of The World Heart Foundation in Washington, D.C.
Cox is best known for the development of the Cox Maze Procedure for treatment of atrial fibrillation. His development of the Maze procedure in 1987 was recognized as the first cure for atrial fibrillation. He has been an invited operating surgeon in more than 40 cases.
He was the recipient of the Distinguished Scientist Award in 1996 by the North American Society of Pacing and Electrophysiology (now known as the Heart Rhythm Society). He was honored for developing surgical treatments for cardiac arrhythmias and recognized for making an outstanding contribution to the field. He also was designated as one of only 29 “pioneers in thoracic and cardiovascular surgery – first 50 years of the specialty” at Hôpital Européen Georges-Pompidou at the University of Paris, France. Cox is the Physician Ambassador of the Year for the Global Atrial Fibrillation Alliance.
Contact: Emily Goad, (615) 322-7048
There are lots of ways to keep up with Vanderbilt. Choose your preferred method: